Wang Yongchao, Kim Sangmi, Kim Il-Man
Vascular Biology Center, Medical College of Georgia, Georgia Regents University , Augusta, GA , USA.
Cancer Center, Medical College of Georgia, Georgia Regents University , Augusta, GA , USA.
Front Oncol. 2014 Jun 10;4:143. doi: 10.3389/fonc.2014.00143. eCollection 2014.
Ovarian cancer (OC) is the second most common and the most fatal gynecologic cancer in the United States. Over the last decade, various targeted therapeutics have been introduced but there has been no corresponding improvement in patient survival mainly because of the lack of effective early detection methods. microRNAs (miRs) are small, non-coding RNAs that regulate gene expression post-transcriptionally. Accumulating data suggest central regulatory roles of miRs in modulating OC initiation, progression, and metastasis. More recently, aberrant miR expression has been also associated with cancer stem cell (CSC) phenotypes and development of CSC chemo-resistance. Here, we review recent advances on miRs and OC metastasis and discuss the concept that miRs are involved in both CSC transformation and subsequent OC metastasis. Finally, we describe the prevalence of circulating miRs and assess their potential utilities as biomarkers for OC diagnosis, prognosis, and therapeutics.
卵巢癌(OC)是美国第二常见且最致命的妇科癌症。在过去十年中,各种靶向治疗药物已被引入,但患者生存率并未相应提高,主要原因是缺乏有效的早期检测方法。微小RNA(miR)是小的非编码RNA,可在转录后调节基因表达。越来越多的数据表明,miR在调节OC的起始、进展和转移中起核心调节作用。最近,异常的miR表达也与癌症干细胞(CSC)表型和CSC化疗耐药性的发展有关。在这里,我们综述了miR与OC转移的最新进展,并讨论了miR参与CSC转化和随后OC转移的概念。最后,我们描述了循环miR的普遍性,并评估了它们作为OC诊断、预后和治疗生物标志物的潜在用途。